BioCentury
ARTICLE | Company News

Advanced Cancer Therapeutics, University of Louisville deal

March 31, 2008 7:00 AM UTC

Advanced Cancer Therapeutics received an exclusive, worldwide license from the university to develop and commercialize 4-IPP and related compounds. The small molecule inhibitor of macrophage migrati...